Enovis Corp Accretion Expense
Enovis Corp (ENOV) reported Accretion Expense of $100.00 thousand for the 3-month period ending 2012-09-28, per its 10-Q filed 2012-10-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2012-10-31
- Enovis Corp accretion expense for the quarter ending 2012-09-28 was $100.00K.
- Enovis Corp accretion expense for the quarter ending 2012-06-29 was $200.00K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month |
|---|---|---|---|
| 2012-09-28 | $100.00K 10-Q · filed 2012-10-31 | $300.00K derived: sum of 2 quarters · filed 2012-10-31 | $500.00K 10-Q · filed 2012-10-31 |
| 2012-06-29 | $200.00K 10-Q · filed 2012-08-07 | $400.00K 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |